Members Only
lock close icon

Maharashtra Govt Says Will Not Allow Sale of Patanjali’s ‘Coronil’

The state government said it will not allow the sale of “anti-COVID” medicine manufactured by Patanjali Ayurveda.

IANS
Politics
Published:
The Maharashtra government on Tuesday, 23 February, said it will not allow the sale of Coronil, an “anti-COVID” medicine manufactured by Baba Ramdev’s Patanjali Ayurveda. Image used for representation. 
i
The Maharashtra government on Tuesday, 23 February, said it will not allow the sale of Coronil, an “anti-COVID” medicine manufactured by Baba Ramdev’s Patanjali Ayurveda. Image used for representation. 
(Photo: PTI)

advertisement

The Maharashtra government on Tuesday, 23 February, said it will not allow the sale of Coronil, an "anti-COVID" medicine manufactured by Baba Ramdev's Patanjali Ayurveda.

The Maha Vikas Aghadi government has pointed out that the Indian Medical Association (IMA) has questioned the trials of Coronil, while the World Health Organisation (WHO) has refuted Patanajali Ayurveda's claims.

Home Minister Anil Deshmukh said that doubts have been raised on the ‘clinical trials’ of Coronil and also regarding false claims on its efficacy for COVID-19 treatment.

"Launching such a drug hurriedly and being endorsed by two senior Central ministers is highly deplorable. Sale of Coronil without proper certification from competent health organisations like WHO, IMA and others will not be permitted in Maharashtra," the minister said.

In June 2020, at the height of the COVID-19 pandemic, Patanjali Ayurveda had launched what it claimed to be India's first Ayurvedic medicines 'Coronil' and 'Swasari' to treat coronavirus.

The company followed it up with the launch of Coronil and a scientific research paper in the presence of Union Health Minister Harsh Vardhan and Union Road Transport Minister Nitin Gadkari on 19 February.

(At The Quint, we question everything. Play an active role in shaping our journalism by becoming a member today.)

Become a Member to unlock
  • Access to all paywalled content on site
  • Ad-free experience across The Quint
  • Early previews of our Special Projects
Continue

Published: undefined

ADVERTISEMENT
SCROLL FOR NEXT